Company intelligence / Profile preview

diaMentis

Québec City, Quebec, Canadadiamentis.com ↗

Ownership: Private
Employees: ~24
Development stage: Commercial

Overview

diaMentis has developed a non-invasive, rapid diagnostic support tool using electroretinography to capture retinal signals and analyze biosignatures specific to schizophrenia, bipolar disorder, and major depressive disorder. The company received Breakthrough Designation from the FDA and was in its final clinical validation phase as of late 2022. Its technology aims to enable faster, more objective diagnosis of severe mental illnesses for clinicians. Validation studies are ongoing at major North American academic centers.[1][3][4][5]

Therapeutic areas: Psychiatry
Modalities: Diagnostic software/device (electroretinography-based biosignature analysis)
Industry: Physiological Monitoring

Drug pipeline

1 asset

macimorelin

Commercial

Indications: Adult growth hormone deficiency, Childhood-onset growth hormone deficiency

Partnerships

Collaborations with leading academic institutions including Harvard University, Feinstein Institute, University of Rochester, University of Montreal, McGill University, and University of Toronto as clinical trial sites[5]

Beyond the preview

Go deeper on diaMentis.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on diaMentis.

Explore the full profile